Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:15 PM ET Form 4
Insider Buying Blackstone Private Real Estate Credit & Income Fund

Blackstone Private Real Estate Credit & Income Fund Insider Blackstone Holdings IV L.P. Buys $2.73M of Stock

Blackstone Holdings IV L.P. bought 104,054 shares of Blackstone Private Real Estate Credit & Income Fund at $26.20 a share, worth $2.73M in total on Oct 21, 2026. Shares held after the trade: 57,118 (+94.3%).

Value
$2.73M
Shares
104,054
Average price
$26.20
Holding change
+94.3%
Trade date
Oct 21, 2026
4:09 PM ET Form 4
Insider Buying Rent the Runway, Inc. RENT

Rent the Runway Insider Nexus Capital Management LP Buys $2.25M of Stock

Nexus Capital Management LP bought 632,922 shares of Rent the Runway, Inc. at $3.55 a share, worth $2.25M in total on Oct 21, 2026. Shares held after the trade: 4,907,316 (+14.8%).

Value
$2.25M
Shares
632,922
Price
$3.55
Holding change
+14.8%
Trade date
Oct 21, 2026
4:08 PM ET Form 4
Insider Buying Rent the Runway, Inc. RENT

Rent the Runway Insider CHS US Investments LLC Buys $1.63M of Stock

CHS US Investments LLC bought 458,245 shares of Rent the Runway, Inc. at $3.55 a share, worth $1.63M in total on Oct 21, 2026. Shares held after the trade: 22,937,292 (+2.0%).

Value
$1.63M
Shares
458,245
Price
$3.55
Holding change
+2.0%
Trade date
Oct 21, 2026
4:01 PM ET Form 4
Insider Buying Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics Director Ramiro Sanchez Buys $98.5K of Stock

Ramiro Sanchez, Director, bought 3,600 shares of Rapport Therapeutics, Inc. at $27.35 a share, worth $98.5K in total on Oct 23, 2026. Shares held after the trade: 3,600.

Value
$98.5K
Shares
3,600
Price
$27.35
Role
Director
Trade date
Oct 23, 2026
2:18 PM ET Form 4
Insider Buying Mexico Equity & Income Fund Inc MXE

Mexico Equity & Income Fund Insider Saba Capital Management L.P. Buys $40.3K of Stock

Saba Capital Management L.P. bought 2,000 shares of Mexico Equity & Income Fund Inc at $20.14 a share, worth $40.3K in total on Oct 22, 2026. Shares held after the trade: 2,424,660 (+0.1%).

Value
$40.3K
Shares
2,000
Price
$20.14
Holding change
+0.1%
Trade date
Oct 22, 2026
12:05 PM ET Form 4
Insider Buying Cascade Real Assets Fund CRAFX

Cascade Real Assets Fund Insider Matthew Eugene Worley Buys $431K of Stock

Matthew Eugene Worley bought 41,910 shares of Cascade Real Assets Fund at $10.29 a share, worth $431K in total on Oct 21, 2026. Shares held after the trade: 41,910.

Value
$431K
Shares
41,909
Price
$10.29
Trade date
Oct 21, 2026
11:55 AM ET Form 4
Insider Buying Vista Credit Strategic Lending Corp.

Vista Credit Strategic Lending CEO and President Gregory T. Galligan Buys $100K of Stock

Gregory T. Galligan, CEO and President, bought 5,144 shares of Vista Credit Strategic Lending Corp. at $19.44 a share, worth $100K in total on Oct 21, 2026. Shares held after the trade: 43,447 (+13.4%).

Value
$100K
Shares
5,143
Price
$19.44
Role
CEO and President
Holding change
+13.4%
Trade date
Oct 21, 2026
9:29 AM ET Form 4
Insider Buying Cleveland-Cliffs Inc. CLF

Cleveland-Cliffs Insider Edilson Camara Buys $99.8K of Stock

Edilson Camara bought 7,400 shares of Cleveland-Cliffs Inc. at $13.49 a share, worth $99.8K in total on Oct 22, 2026. Shares held after the trade: 64,717 (+12.9%).

Value
$99.8K
Shares
7,400
Price
$13.49
Holding change
+12.9%
Trade date
Oct 22, 2026
8:57 PM ET Form 4
Insider Buying Agora, Inc. API

Agora CEO Bin Zhao Buys $168K of Stock

Bin Zhao, CEO, bought 38,267 shares of Agora, Inc. at $4.36 to $4.46 a share (average $4.40) in 4 transactions, worth $168K in total between Oct 19, 2026 and Oct 22, 2026. Shares held after the trade: 2,204,735 (+0.4%).

Value
$168K
Shares
38,267
Average price
$4.40
Role
CEO
Holding change
+0.4%
Trade date
Oct 19, 2026 to Oct 22, 2026
7:38 PM ET Form 4
Insider Buying Liqtech International Inc LIQT

Liqtech International Insider Peyton Boswell Buys $50K of Stock

Peyton Boswell bought 50,000 shares of Liqtech International Inc at $1.00 a share, worth $50K in total on Jun 5, 2026. Shares held after the trade: 171,305 (+41.2%).

Value
$50K
Shares
50,000
Price
$1.00
Holding change
+41.2%
Trade date
Jun 5, 2026
6:45 PM ET Form 4
Insider Buying SenesTech, Inc. SNES

SenesTech Insider Glenbrook Capital Management Buys $68.8K of Stock

Glenbrook Capital Management bought 96,375 shares of SenesTech, Inc. at $0.6746 to $0.7385 a share (average $0.7144) in 2 transactions, worth $68.8K in total between Oct 20, 2026 and Oct 21, 2026. Shares held after the trade: 2,159,473 (+2.9%).

Value
$68.8K
Shares
96,375
Average price
$0.7144
Holding change
+2.9%
Trade date
Oct 20, 2026 to Oct 21, 2026
6:35 PM ET Form 4
Insider Buying Dole plc DOLE

Dole Insider Pale Fire Capital SE Buys $8.55M of Stock

Pale Fire Capital SE bought 648,356 shares of Dole plc at $13.12 to $13.39 a share (average $13.19) in 3 transactions, worth $8.55M in total between Oct 20, 2026 and Oct 22, 2026. Shares held after the trade: 10,282,620 (+1.6%).

Value
$8.55M
Shares
648,356
Average price
$13.19
Holding change
+1.6%
Trade date
Oct 20, 2026 to Oct 22, 2026
5:44 PM ET Form 4
Insider Buying Anixa Biosciences Inc ANIX

Anixa Biosciences CEO Amit Kumar Buys $21.8K of Stock

Amit Kumar, CEO, bought 8,000 shares of Anixa Biosciences Inc at $2.72 a share, worth $21.8K in total on Oct 22, 2026. Shares held after the trade: 680,000 (+1.2%).

Value
$21.8K
Shares
8,000
Price
$2.72
Role
CEO
Holding change
+1.2%
Trade date
Oct 22, 2026
5:44 PM ET Form 4
Insider Buying 5C Lending Partners Corp.

5C Lending Partners 10% Owner Msd Capital L.P. Buys $9.57M of Stock

Msd Capital L.P., 10% Owner, bought 390,857 shares of 5C Lending Partners Corp. at $24.48 a share, worth $9.57M in total on Sep 17, 2026. Shares held after the trade: 4,249,305 (+10.1%).

Value
$9.57M
Shares
390,857
Price
$24.48
Role
10% Owner
Holding change
+10.1%
Trade date
Sep 17, 2026
5:38 PM ET Form 4
Insider Buying BNY Mellon Strategic Municipals, Inc. LEO

BNY Mellon Strategic Municipals Insider Saba Capital Management L.P. Buys $263K of Stock

Saba Capital Management L.P. bought 45,831 shares of BNY Mellon Strategic Municipals, Inc. at $5.73 a share, worth $263K in total on Oct 21, 2026. Shares held after the trade: 6,482,189 (+0.7%).

Value
$263K
Shares
45,831
Price
$5.73
Holding change
+0.7%
Trade date
Oct 21, 2026
5:27 PM ET Form 4
Insider Buying Mexico Equity & Income Fund Inc MXE

Mexico Equity & Income Fund Insider Saba Capital Management L.P. Buys $327K of Stock

Saba Capital Management L.P. bought 16,035 shares of Mexico Equity & Income Fund Inc at $20.42 a share, worth $327K in total on Oct 21, 2026. Shares held after the trade: 2,422,660 (+0.7%).

Value
$327K
Shares
16,035
Price
$20.42
Holding change
+0.7%
Trade date
Oct 21, 2026
5:04 PM ET Form 4
Insider Buying Corebridge Financial, Inc. CRBG

Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $6.77M of Stock

Nippon Life Insurance Co, 10% Owner, bought 193,357 shares of Corebridge Financial, Inc. at $35.01 a share, worth $6.77M in total on Oct 20, 2026. Shares held after the trade: 130,203,484 (+0.1%).

Value
$6.77M
Shares
193,357
Price
$35.01
Role
10% Owner
Holding change
+0.1%
Trade date
Oct 20, 2026
4:57 PM ET Form 4
Insider Buying Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics Director Paul M. Silva Buys $99.6K of Stock

Paul M. Silva, Director, bought 3,680 shares of Rapport Therapeutics, Inc. at $27.07 a share, worth $99.6K in total on Oct 22, 2026. Shares held after the trade: 3,680.

Value
$99.6K
Shares
3,680
Price
$27.07
Role
Director
Trade date
Oct 22, 2026
4:57 PM ET Form 4
Insider Buying Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics Director Wendy B. Young Buys $100K of Stock

Wendy B. Young, Director, bought 3,789 shares of Rapport Therapeutics, Inc. at $26.39 a share, worth $100K in total on Oct 22, 2026. Shares held after the trade: 13,289 (+39.9%).

Value
$100K
Shares
3,789
Price
$26.39
Role
Director
Holding change
+39.9%
Trade date
Oct 22, 2026
4:57 PM ET Form 4
Insider Buying Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics Director Steven M. Paul Buys $974K of Stock

Steven M. Paul, Director, bought 35,714 shares of Rapport Therapeutics, Inc. at $27.28 a share, worth $974K in total on Oct 22, 2026. Shares held after the trade: 77,380 (+85.7%).

Value
$974K
Shares
35,714
Price
$27.28
Role
Director
Holding change
+85.7%
Trade date
Oct 22, 2026
4:56 PM ET Form 4
Insider Buying Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics Director John Maraganore Buys $249K of Stock

John Maraganore, Director, bought 9,411 shares of Rapport Therapeutics, Inc. at $26.38 to $26.92 a share (average $26.45) in 2 transactions, worth $249K in total on Oct 22, 2026. Shares held after the trade: 9,411 (+14.2%).

Value
$249K
Shares
9,411
Average price
$26.45
Role
Director
Holding change
+14.2%
Trade date
Oct 22, 2026
4:50 PM ET Form 4
Insider Buying XAI Floating Rate & Alternative Income Trust XFLT

XAI Floating Rate & Alternative Income Trust Insider John Yogi Spence Buys $34.1K of Stock

John Yogi Spence bought 2,000 shares of XAI Floating Rate & Alternative Income Trust at $17.07 a share, worth $34.1K in total on Oct 21, 2026. Shares held after the trade: 114,357 (+1.8%).

Value
$34.1K
Shares
2,000
Price
$17.07
Holding change
+1.8%
Trade date
Oct 21, 2026
4:17 PM ET Form 4
Insider Buying BNY Mellon Strategic Municipal Bond Fund, Inc. DSM

BNY Mellon Strategic Municipal Bond Fund Insider Saba Capital Management L.P. Buys $109K of Stock

Saba Capital Management L.P. bought 20,575 shares of BNY Mellon Strategic Municipal Bond Fund, Inc. at $5.32 a share, worth $109K in total on Oct 21, 2026. Shares held after the trade: 5,436,073 (+0.4%).

Value
$109K
Shares
20,575
Price
$5.32
Holding change
+0.4%
Trade date
Oct 21, 2026
3:23 PM ET Form 4
Insider Buying New Germany Fund Inc GF

New Germany Fund Insider Saba Capital Management L.P. Buys $25.7K of Stock

Saba Capital Management L.P. bought 2,462 shares of New Germany Fund Inc at $10.44 a share, worth $25.7K in total on Oct 21, 2026. Shares held after the trade: 3,896,172 (+0.1%).

Value
$25.7K
Shares
2,462
Price
$10.44
Holding change
+0.1%
Trade date
Oct 21, 2026
12:55 PM ET Form 4
Insider Buying Ellsworth Growth & Income Fund Ltd ECF

Ellsworth Growth & Income Fund Insider Saba Capital Management L.P. Buys $30.1K of Stock

Saba Capital Management L.P. bought 2,600 shares of Ellsworth Growth & Income Fund Ltd at $11.58 a share, worth $30.1K in total on Oct 21, 2026. Shares held after the trade: 1,792,455 (+0.1%).

Value
$30.1K
Shares
2,600
Price
$11.58
Holding change
+0.1%
Trade date
Oct 21, 2026
8:15 AM ET Form 4
Insider Buying AgomAb Therapeutics NV AGMB

AgomAb Therapeutics Insider David R. Epstein Buys $88.8K of Stock

David R. Epstein bought 10,000 shares of AgomAb Therapeutics NV at $8.86 to $8.90 a share (average $8.88) in 2 transactions, worth $88.8K in total on Oct 21, 2026. Shares held after the trade: 25,000 (+25.0%).

Value
$88.8K
Shares
10,000
Average price
$8.88
Holding change
+25.0%
Trade date
Oct 21, 2026
7:24 PM ET Form 4
Insider Buying FB Financial Corp FBK

FB Financial Insider Orrin H. Ingram II Buys $1.54M of Stock

Orrin H. Ingram II bought 29,081 shares of FB Financial Corp at $52.68 to $53.11 a share (average $52.88) in 2 transactions, worth $1.54M in total on Oct 20, 2026. Shares held after the trade: 124,391 (+12.2%).

Value
$1.54M
Shares
29,081
Average price
$52.88
Holding change
+12.2%
Trade date
Oct 20, 2026
6:21 PM ET Form 4
Insider Buying Bluerock Private Real Estate Fund BPRE

Bluerock Private Real Estate Fund Insider Ramin Kamfar Buys $3.35M of Stock

Ramin Kamfar bought 271,555 shares of Bluerock Private Real Estate Fund at $12.25 to $12.43 a share (average $12.32) in 3 transactions, worth $3.35M in total between Oct 19, 2026 and Oct 21, 2026. Shares held after the trade: 2,720,423 (+4.4%).

Value
$3.35M
Shares
271,555
Average price
$12.32
Holding change
+4.4%
Trade date
Oct 19, 2026 to Oct 21, 2026
5:47 PM ET Form 4
Insider Buying Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics CFO Troy A. Ignelzi Buys $144K of Stock

Troy A. Ignelzi, CFO, bought 5,500 shares of Rapport Therapeutics, Inc. at $26.10 a share, worth $144K in total on Oct 21, 2026. Shares held after the trade: 15,500 (+55.0%).

Value
$144K
Shares
5,500
Price
$26.10
Role
CFO
Holding change
+55.0%
Trade date
Oct 21, 2026
5:23 PM ET Form 4
Insider Buying MSD Investment Corp. MSD

MSD Investment Insider Brian S. Williams Buys $311K of Stock

Brian S. Williams bought 13,130 shares of MSD Investment Corp. at $23.68 a share, worth $311K in total on Oct 19, 2026. Shares held after the trade: 49,473 (+36.1%).

Value
$311K
Shares
13,129
Price
$23.68
Holding change
+36.1%
Trade date
Oct 19, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.